Dr.-Ing. Matthias Rüdt studied chemistry and biotechnology at ETH Zurich with an exchange at Stanford University for his Master thesis. After a two year interlude in biopharmaceutical downstream process development at Novartis, he returned to academia for his PhD (Doktor der Ingenieurswissenschaften, completed with summa cum laude) with a subsequent PostDoc at the Karlsruhe Institute of Technology (KIT) focusing on Process Analytical Technology (PAT) for the downstream process of biologics. Returning to industry, Matthias worked at Novartis and Roche in clinical and commercial manufacturing before assuming his current position as associate professor at HES-SO Vallais-Wallis.
During his previous career, Matthias Rüdt authored publications on PAT, downstream processing, chemometrics, mechanistic modeling, issued a patent and received multiple prices for conference publications. His current research interests are: